HomeCompareUMTAF vs SBUX

UMTAF vs SBUX: Dividend Comparison 2026

UMTAF yields 58.82% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 UMTAF wins by $19374.11M in total portfolio value
10 years
UMTAF
UMTAF
● Live price
58.82%
Share price
$0.60
Annual div
$0.35
5Y div CAGR
41.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19374.28M
Annual income
$17,550,348,472.66
Full UMTAF calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — UMTAF vs SBUX

📍 UMTAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUMTAFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UMTAF + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UMTAF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UMTAF
Annual income on $10K today (after 15% tax)
$5,000.00/yr
After 10yr DRIP, annual income (after tax)
$14,917,796,201.76/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, UMTAF beats the other by $14,917,735,735.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UMTAF + SBUX for your $10,000?

UMTAF: 50%SBUX: 50%
100% SBUX50/50100% UMTAF
Portfolio after 10yr
$9687.22M
Annual income
$8,775,209,804.56/yr
Blended yield
90.59%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

UMTAF
No analyst data
Altman Z
1.2
Piotroski
6/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UMTAF buys
0
SBUX buys
0
No recent congressional trades found for UMTAF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUMTAFSBUX
Forward yield58.82%2.84%
Annual dividend / share$0.35$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR41.5%48.3%
Portfolio after 10y$19374.28M$167.0K
Annual income after 10y$17,550,348,472.66$71,136.45
Total dividends collected$19239.07M$136.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: UMTAF vs SBUX ($10,000, DRIP)

YearUMTAF PortfolioUMTAF Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$19,024$8,323.53$11,121$420.68+$7.9KUMTAF
2$41,295$20,939.74$12,548$648.40+$28.7KUMTAF
3$104,296$60,110.37$14,440$1,013.98+$89.9KUMTAF
4$312,364$200,767.26$17,068$1,617.30+$295.3KUMTAF
5$1,129,398$795,168.21$20,912$2,649.52+$1.11MUMTAF
6$5,010,504$3,802,048.80$26,875$4,499.29+$4.98MUMTAF
7$27,667,405$22,306,165.71$36,771$8,014.12+$27.63MUMTAF
8$192,490,433$162,886,309.88$54,542$15,197.11+$192.44MUMTAF
9$1,704,606,994$1,498,642,230.13$89,602$31,242.49+$1704.52MUMTAF
10$19,374,277,956$17,550,348,472.66$167,011$71,136.45+$19374.11MUMTAF

UMTAF vs SBUX: Complete Analysis 2026

UMTAFStock

Genertec Universal Medical Group Company Limited, together with its subsidiaries, offers financing and advisory services in the People's Republic of China. It operates in two segments, Finance and Advisory and Hospital Group. The Finance and Advisory segment provides direct finance leasing; sale and leaseback; factoring; operating leases; and advisory services. The Hospital Group segment engages in the provision of medical services; hospital and healthcare management; and import and export trading businesses, as well as trading of medical-related goods. The company is also involved in the provision of medical technology; hospital digitalization, construction, and management services; property management; and medical consulting services. It serves patients, hospitals, medical equipment suppliers, and other public institutions. The company was formerly known as Universal Medical Financial & Technical Advisory Services Company Limited and changed its name to Genertec Universal Medical Group Company Limited in July 2018. Genertec Universal Medical Group Company Limited was founded in 1984 and is headquartered in Beijing, China.

Full UMTAF Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this UMTAF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UMTAF vs SCHDUMTAF vs JEPIUMTAF vs OUMTAF vs KOUMTAF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.